Finance

Lists
SYMBIOTEC:NSE
Symbiotec Pharmalab Ltd
₹1,197.30
+1.75%
(+20.55) 1D
Oct 1, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SYMBIOTEC...
Open
₹1,194.00
High
₹1,246.00
Low
₹1,161.10
Mkt. cap
77.11B
Avg. vol.
2.30M
Volume
3.71M
P/E ratio
81.53
52-wk high
₹1,246.00
52-wk low
₹934.20
EPS
₹14.68
No. of employees
2K
Open
₹1,194.00
High
₹1,246.00
Low
₹1,161.10
Mkt. cap
77.11B
Avg. vol.
2.30M
Volume
3.71M
P/E ratio
81.53
52-wk high
₹1,246.00
52-wk low
₹934.20
EPS
₹14.68
No. of employees
2K
News stories
From web sources and news partners
About Symbiotec Pharmalab Ltd
CEO-
Employees1.92K
Founded1995
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Jun 2025
Jun 2026
Revenue
2.03B
2.18B
Cost of goods sold
830.48M
755.59M
Cost of revenue
830.48M
755.59M
Research and development expenses
-
-
Total research and development expenses
-
-
Selling, general, and admin expenses
354.60M
464.21M
Operating expense
722.14M
1.19B
Total operating expenses
1.55B
1.95B
Operating income
479.10M
233.73M
Other non operating income
-400.00K
3.38M
EBT including unusual items
448.22M
175.32M
EBT excluding unusual items
429.79M
175.32M
Income tax expense
149.02M
34.71M
Effective tax rate
33.25%
19.80%
Other operating expenses
262.46M
509.73M
Net income
299.20M
140.56M
Net profit margin
14.73%
6.44%
Earnings per share
-
-
Interest and investment income
660.00K
-
Interest expense
-48.41M
-61.79M
Net interest expenses
-47.75M
-61.79M
Depreciation and amortization charges
105.08M
218.24M
EBITDA
581.03M
363.51M
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
Google apps